Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients

Patients with type 2 diabetes mellitus (T2DM) and obesity are at high risk of developing cardiovascular disease (CVD). Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter (SGLT-2) inhibitors have been shown to prevent CVD in T2DM patients. Additionally, the tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Uneda, Kazushi, Kawai, Yuki, Yamada, Takayuki, Kinguchi, Sho, Azushima, Kengo, Kanaoka, Tomohiko, Toya, Yoshiyuki, Wakui, Hiromichi, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119733/
https://www.ncbi.nlm.nih.gov/pubmed/33986377
http://dx.doi.org/10.1038/s41598-021-89620-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119733/
https://www.ncbi.nlm.nih.gov/pubmed/33986377
http://dx.doi.org/10.1038/s41598-021-89620-7

Ejemplares similares